SciELO - Scientific Electronic Library Online

 
vol.93 número3Impacto clínico de la localización infrapatelar en pacientes con enfermedad arterial periférica sintomáticaComorbilidades y síntomas clínicos que pueden modificar la función miocárdica: estudio transversal con PET/TC índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Archivos de cardiología de México

versão On-line ISSN 1665-1731versão impressa ISSN 1405-9940

Resumo

GASCA-PINEDA, Ricardo et al. Economic burden of hypercholesterolemia in high risk of cardiovascular disease population in Mexico. Arch. Cardiol. Méx. [online]. 2023, vol.93, n.3, pp.328-335.  Epub 04-Set-2023. ISSN 1665-1731.  https://doi.org/10.24875/acm.22000195.

Objective:

To estimate the direct and indirect economic burden of hypercholesterolemia in patients with high risk of a cardiovascular event, specifically there were defined 5 groups of patients: 1) familial hypercholesterolemia; 2, 3 and 4) patients with hypercholesterolemia and background of diabetes, myocardial infarction or stroke; 5) diabetes, myocardial infarction and hypercholesterolemia (very high-risk patients) from the Mexican public healthcare institutions.

Methods:

For the estimation of the direct costs the items included correspond to: outpatient care, pharmacological treatment, inpatient hospital care, and surgical procedures. For indirect economic burden, death certificates, before the end of the productive age due to hypercholesterolemia were calculated (premature mortality).

Results:

The direct economic burden for the 5 groups of patients at risk is MXN $39,601,464,154 (USD $1,987,526,432), while the indirect economic burden amounts to MXN $121,646,689 (USD $6,105,229).

Conclusions:

The economic impact of hypercholesterolemia in patients with high cardiovascular risk is $39,723,110,843 (equivalent to USD $1,993,631,661) and corresponds to the 0.16% of GDP.

Palavras-chave : Hypercholesterolemia; Economic burden; Indirect costs.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )